[Control of bone remodeling by leptin and sympathetic nervous system].
Takeda
Shu
S
Department of Orthopedics/21COE, Tokyo Medical and Dental University Graduate School.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D015519:Bone Density / Q000187:drug effects / Q000235:genetics; D016723:Bone Remodeling / Q000235:genetics; D001842:Bone and Bones / Q000378:metabolism*; D002453:Cell Cycle / Q000235:genetics; D050723:Fractures, Bone / Q000517:prevention & control; D020738:Leptin / Q000502:physiology*; D051379:Mice; D009479:Neuropeptides / Q000502:physiology; D010006:Osteoblasts / Q000166:cytology; D010012:Osteogenesis / Q000235:genetics; D018013:Receptors, Neuropeptide / Q000502:physiology; D015398:Signal Transduction / Q000502:physiology; D013564:Sympathetic Nervous System / Q000502:physiology*
D000319:Adrenergic beta-Antagonists; D020738:Leptin; D009479:Neuropeptides; D018013:Receptors, Neuropeptide